Evie Merinopoulou
Senior Director, Real-World Evidence
Evie Merinopoulou is Senior Director, Real-World Evidence, at Cytel. She is a health economist and real-world data scientist working on applications of real-world evidence in support of regulatory and HTA decision-making.
Evie has worked in the healthcare consulting industry for over 10 years, currently leading the design and execution of observational research projects using global real-world data. She particularly focuses on projects involving real-world synthetic control arms, quantitative bias analysis, head-to-head comparisons using target trial emulation, and transportability analysis.
Related Articles
August 28, 2026
Read More
White Paper – The FDA’s Shift to One Pivotal Trial Plus Confirmatory Evidence: A New Era of Evidence for Drug Development
August 13, 2024
Read More
External Validity Bias in HTA Submissions: A Case for Transportability Methods
August 1, 2024
Read More
The Role of External Data in Oncology Drug Development
June 18, 2024
Read More
Planning Strategies for Externally Controlled Trials: Insights from ISPOR US 2024
June 13, 2024
Read More
Webinar – Oncology Trials: External Control Arms and Bayesian Borrowing
November 3, 2023
Read More
